Board

StreetInsider.com

Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD, to Board of Directors

NORWOOD, Mass., Sept. 26, 2022 /PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an immunology company, today announced the appointment of Anne Altmeyer, PhD, MBA, MPH to its Board of Directors. “Anne is a dynamic leader with a proven track record of advancing R&D programs and creating enterprise value through successful …

Corbus Pharmaceuticals Appoints Anne Altmeyer, PhD, to Board of Directors Read More »

Maze Therapeutics Appoints Sekar Kathiresan, MD, to its Board of Directors

Maze Therapeutics Appoints Sekar Kathiresan, MD, to its Board of Directors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a company that translates genetic knowledge into new precision medicines, today announced that Sekar Kathiresan, MD, co-founder of Maze, has joined the company’s board of directors. Dr. Kathiresan is an experienced cardiologist, co-founder and CEO of Verve Therapeutics, and a lecturer in medicine at Harvard Medical School. His work …

Maze Therapeutics Appoints Sekar Kathiresan, MD, to its Board of Directors Read More »

Kathy Butler, supervisor of student affairs, addresses the Marion City School Board regarding the district's contract with OhioGuidestone during Monday's board meeting.

Tensions erupt at Marion City Schools Board meeting on mental health

A disagreement over contracts for emergency student mental health resources arose again at the Marion City Schools School Board meeting in September on Monday. Following the August board meeting, when board member Rocky Ratliff accused Acting Superintendent Steve Mazzi of not wanting to discuss contracts in public when asked to ask his questions at the …

Tensions erupt at Marion City Schools Board meeting on mental health Read More »

Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy

Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy

Members Bradley BernsteinMD, Ph.D., Paula Canondoctorate, howard changMD, Ph.D., and Ahmad (Mo) KhalilPh.D., will guide the advancement of the company’s epigenetic editing platform and key programs Scientific Advisors Join Chroma Founders, Luke Gilbertdoctorate, Keith Young MD., Ph.D., David Liudoctorate, Angelo Lombardodoctorate, Luigi NaldiniMD, Ph.D., and jonathan weismanPh.D., expanding the company’s world-class team of genomic medicine …

Chroma Medicine Announces Formation of Scientific Advisory Board of Global Experts in Gene Editing and Cell and Gene Therapy Read More »